Our mission
is to improve survival of children diagnosed with rare brain tumor by:
![DiagnosticTools_Icon DiagnosticTools_Icon](https://lab.research.sickkids.ca/annie-huang/wp-content/uploads/sites/91/2020/07/DiagnosticTools_Icon-120x120.png)
Developing better diagnostic tools
![DrugsTreatment_Icon DrugsTreatment_Icon](https://lab.research.sickkids.ca/annie-huang/wp-content/uploads/sites/91/2020/07/DrugsTreatment_Icon-120x120.png)
Developing new drugs and treatments
![World_Icon World_Icon](https://lab.research.sickkids.ca/annie-huang/wp-content/uploads/sites/91/2020/07/World_Icon-120x120.png)
Linking doctors and researchers around the world
![Family_Icon Family_Icon](https://lab.research.sickkids.ca/annie-huang/wp-content/uploads/sites/91/2020/07/Family_Icon-120x120.png)
Connecting families with clinical trials
![howwework_800x600](https://lab.research.sickkids.ca/annie-huang/wp-content/uploads/sites/91/2020/07/howwework_800x600.jpg)
Linking doctors and researchers around the world
- The RBTC collects tumor, CSF and blood and clinical data from newly diagnosed or prior patients with suspected or confirmed rare brain tumor diagnoses from global member sites
- Biomaterials are used for
- Generation of cell lines for drug studies,
- Genetic, molecular and histopathologic studies to investigate or confirm diagnoses
- Genomic studies to discover nature of tumor-causing processes
- Clinical data of rare brain tumor patients including pathology reports, treatment and imaging information are linked with molecular findings and shared with the global community to
- Improve clinical recognition and develop more specific and sensitive diagnostic assays
- Inform new approaches or types of therapies for rare brain tumor patients